The oncogenic effects of IL-6 are facilitated through IL-6 receptor (IL-6R) signalling, which promotes the PI3K–AKT pathway, thus stimulating PCa cell growth and survival rates (84, 85). The gene discussed is IL6R; the disease is posterior cortical atrophy.